SynthesisFrontiers in oncology2022

Comparative Efficacy and Safety of Anti-PD-1/PD-L1 for the Treatment of Non-Small Cell Lung Cancer: A Network Meta-Analysis of 13 Randomized Controlled Studies.

Maofen Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.